Allergy Therapeutics (UK) Limited – Trademark Portfolio
Entity Type: 03
Allergy Therapeutics (UK) Limited holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 9 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include BIRCOVA, POLLINEX, AJVAXTURE, BIRCHGARD, and GRASSMUNO. The owner is based in West Sussex BN14 8SA.
Dominion Way Worthing
West Sussex BN14 8SA , GB
Showing of trademarks Trademarks
Trademark Classifications
Allergy Therapeutics (UK) Limited's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Allergy Therapeutics (UK) Limited have?
Allergy Therapeutics (UK) Limited has 9 U.S. trademarks filed with the USPTO. Of these, 7 registered, 1 abandoned, 1 cancelled.
What trademark classes does Allergy Therapeutics (UK) Limited file in?
Allergy Therapeutics (UK) Limited files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Allergy Therapeutics (UK) Limited's most well-known trademarks?
Allergy Therapeutics (UK) Limited's registered trademark portfolio includes well-known marks such as BIRCOVA, POLLINEX, AJVAXTURE, BIRCHGARD, and GRASSMUNO. These are among 7 currently registered trademarks in the portfolio.
What is Allergy Therapeutics (UK) Limited's trademark registration success rate?
Allergy Therapeutics (UK) Limited has a 78% trademark registration rate, with 7 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.